InSite Vision Determines that an Unsolicited Offer from a Global Pharmaceutical Company to Acquire InSite for $0.35 per Share in Cash Constitutes a “Company Superior Proposal” Sep 4, 2015 05:49PM
InSite Vision Receives Second Unsolicited Acquisition Proposal for $0.35 per Share From a Global Pharmaceutical Company Sep 3, 2015 04:12PM
InSite Vision Receives Unsolicited Proposal from a Multi-National Pharmaceutical Company Aug 10, 2015 08:30AM
Roth Capital Downgrades Insite Vision (INSV) to Neutral Jun 17, 2015 08:43AM
InSite Vision to Merge With Canadian Biotechnology Company QLT Jun 8, 2015 11:02AM